The challenge of blocking a wider family members of EGFR against head and neck squamous cell carcinomas

Oral Oncology
Javier Martinez-Useros, Jesus Garcia-Foncillas

Abstract

Head and neck squamous cell carcinoma (HNSCC) represent 95% of head and neck cancer with an incidence of over half a million people globally. The prognosis for patients with recurrent or metastatic HNSCC is generally poor with low 5-year survival rates despite treatment advances over the past few decades. Consequently, it is essential to search for new biomarkers and effective therapy options to optimize HNSCC treatment. Epidermal growth factor receptor (EGFR) is overexpressed in approximately 90% of tumours. EGFR has become one of most common targets for new therapies being investigated in HNSCC. In this way, multiple therapies targeting EGFR in HNSCC have been tested but response rates are still low especially in the recurrent or metastatic setting. This has been attributed to mechanisms of resistance to EGFR-targeted therapies. Afatinib, an oral small molecule ErbB Family Blocker that irreversibly binds to ErbB1 (EGFR), ErbB2 (HER2) and ErbB4 (HER4), is being investigated in HNSCC treatment with encouraging phase II results and several ongoing phase III trials. Results of these trials will help to understand the place of afatinib in the HNSCC treatment armamentarium.

References

Oct 1, 1987·American Journal of Surgery·C KotwallD P Shedd
Nov 7, 2002·Journal of the National Cancer Institute·Anthony T C ChanPhilip J Johnson
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ezra E W CohenEverett E Vokes
Jun 11, 2004·The New England Journal of Medicine·Jin-Ching LinRong-San Jiang
Sep 3, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E GuardiolaX Pivot
Dec 1, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Larry H KalishElizabeth A Musgrove
Feb 25, 2005·The New England Journal of Medicine·Susumu KobayashiBalázs Halmos
Apr 15, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M-C Etienne-GrimaldiG Milano
Jul 1, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-L Lefebvre
Jul 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstMerrill S Kies
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Barbara BurtnessUNKNOWN Eastern Cooperative Oncology Group
Dec 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ezra E W CohenEverett E Vokes
Dec 6, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Judith Loeffler-RaggHeinz Zwierzina
Jan 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul M WeinbergerAmanda Psyrri
Feb 10, 2006·The New England Journal of Medicine·James A BonnerK Kian Ang
Jun 17, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Benedetta Peruzzi, Donald P Bottaro
Sep 5, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John C SokJennifer R Grandis
Jan 17, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Im Il NaYoon Sang Shim
Mar 1, 2007·Nature Clinical Practice. Oncology·Tanguy Y SeiwertEverett E Vokes
May 15, 2007·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Christina SchützeMechthild Krause
Dec 21, 2007·The New England Journal of Medicine·M Luana PoetaWayne M Koch
Sep 12, 2008·The New England Journal of Medicine·Jan B VermorkenRicardo Hitt
Feb 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William A MichaudJames W Rocco
Mar 12, 2009·Journal of the National Cancer Institute·Theodore RampiasAmanda Psyrri
May 28, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lynn M KnowlesJill M Siegfried
Jul 30, 2009·Clinical & Experimental Metastasis·Pirus GhadjarYitzhak Zimmer
Aug 12, 2009·Expert Opinion on Pharmacotherapy·Quintin PanTheodoros N Teknos
Apr 22, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lucy F ChenJennifer R Grandis
May 11, 2010·The Lancet Oncology·Shanthi MarurArlene A Forastiere
Jun 10, 2010·The New England Journal of Medicine·K Kian AngMaura L Gillison
Jun 19, 2010·Expert Opinion on Emerging Drugs·Christopher Fung, Jennifer R Grandis
Aug 4, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy A YapRuth Plummer
Aug 11, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Danny RischinGrant A McArthur
Feb 5, 2011·Cancer Biology & Therapy·Toni M BrandDeric L Wheeler
Feb 15, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M R PosnerK J Cullen
Mar 25, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Pernille LassenUNKNOWN Danish Head and Neck Cancer Group (DAHANCA)

❮ Previous
Next ❯

Citations

Jan 25, 2017·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Yoon Se LeeSang Yoon Kim
Mar 7, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D HashimP Boffetta
Dec 3, 2016·Oncology Letters·Agnieszka SobeckaWiktoria Maria Suchorska
Feb 22, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Maria Olivero-AcostaJesus Olivero-Verbel
Jul 25, 2018·Amino Acids·Franziska StrieseHans-Jürgen Pietzsch
Jan 24, 2019·Mediators of Inflammation·Sandra Rayego-MateosMarta Ruiz-Ortega
Nov 5, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laura Q M ChowRenato G Martins
Jan 29, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D HashimP Boffetta

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.